Clinical trials: Bone Remodeling
Osteopenia
The Effect of Semaglutide on Bone Turnover in Patients With Increased Risk of Bone Fracture
The hypothesis for this study is that the GLP-1Ra Semaglutide has a positive effect on the balance between build-up and degradation as well as the strength of the bones in men and women aged 40-85 years at increased risk of bone…
- Trial name
- NCT04702516
- Testing
- Ozempic
- Where
- Denmark
- Volunteers
- 64 people, healthy volunteers welcome
- Sponsor
- Morten Frost